Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Jim Cramer’s guide to investing: Pay attention to big insider buying
CNBC’s Jim Cramer said investors should usually wait until high-quality stocks have had a pullback before buying. But sometimes it’s worth buying some stock at the top, especially if a company engages in significant insider buying. Not to be confused with insider trading, insider buying is based on public information and occurs when executives buy…
Options Action: Tesla jumps ahead of Q3 production and delivery numbers
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders talk Tesla. 01:18 Fri, Sep 29 20236:08 PM EDT
Rep. French Hill on bitcoin ETF approval: We need a change in the ‘regulatory posture’ in Washington
House Financial Services Committee vice chairman and Digital Assets Committee chairman Rep. French Hill (R-Ark.) joins ‘Squawk Box’ to discuss the SEC’s approval of spot bitcoin ETFs, what it means for crypto regulation in Congress, and more.
Watch the full discussion on Disney with RBC’s Kutgun Maral and Cowen’s Doug Cruetz
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Kutgun Maral of RBC Capital Markets and Doug Creutz of Cowen join ‘The Exchange’ to discuss streaming stocks like Netflix, Paramount Global and Disney. 07:44 Mon, Jul 18 20221:58 PM EDT
Crowdsourcing your bottom line
Internet lingerie startup “Adore Me” aims to disrupt the U.S. lingerie market. One strategy their using, is to crowdsource the designs they bring to market.
Inflation is still transitory unless signs show otherwise: Austan Goolsbee
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Austan Goolsbee from University of Chicago Booth School of Business explains why there is still “another shoe to drop” before investors think the inflation is permanent. 03:04 Mon, May 17 202112:22 AM EDT
